Executive record

Roger Kornberg

Public governance roles and source-backed Claims for this individual.

  • Director

Alpha ID: alpha:person:roger-kornbergVersion: public-0As of: 2026-09-28

Follow
More
Challenge a Claim

Identity

unclaimed

Evidence

corroborated

Evaluation

Unknown

Monitoring

Unknown

Authority

Unknown

Freshness

Observed 2026-09-28

Key Claims

Roles and authority

OrganizationRoleModuleGranted byFromTo
Cocrystal Pharma, Inc.DirectorDirectorUnavailable2020-01-01Unavailable
Xenetic Biosciences, Inc.DirectorDirectorUnavailable2016-01-01Unavailable

Exposure

Person-level exposure is withheld from public Executive records. Published exposure, where available, attaches to the relevant Enterprise record.

Evidence, history and coverage

Additional published Claims

Published evidence records

7 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. COCP 10-K executive officers

    sec filing · Source published: Mar 31, 2026 · Retrieved: May 16, 2026

    Supports 6 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at Cocrystal Pharma, Inc. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Chairman and Director · Claim reviewed: May 16, 2026
    • Other Company Role: Roger Kornberg is also linked to Stanford Medical School as Professor of Structural Biology. · Claim reviewed: May 16, 2026
    • Technology background: Technology background reported in filings · Claim reviewed: May 16, 2026

  2. XBIO DEF 14A director slate

    sec filing · Source published: Oct 31, 2025 · Retrieved: May 16, 2026

    Supports 6 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Board role: Board role: Director · Claim reviewed: May 16, 2026
    • Committee assignments: Committee assignments: Nominating/Governance · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at Stanford University · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  3. Open source

    sec proxy · Source published: Oct 31, 2025 · Retrieved: Apr 28, 2026

    Supports 1 claim
    • Professional Role: Director at Xenetic Biosciences, Inc. · Claim reviewed: May 16, 2026

  4. COCP DEF 14A director slate

    sec filing · Source published: May 5, 2025 · Retrieved: May 15, 2026

    Supports 2 claims
    • Board role: Board role: Chair · Claim reviewed: May 15, 2026
    • Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 15, 2026

  5. Open source

    sec proxy · Source published: May 5, 2025 · Retrieved: Apr 28, 2026

    Supports 1 claim
    • Professional Role: Director at Cocrystal Pharma, Inc. · Claim reviewed: May 16, 2026

  6. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Cocrystal Pharma, Inc. · Claim reviewed: May 16, 2026

  7. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Xenetic Biosciences, Inc. · Claim reviewed: May 16, 2026